Transgene SA TRGNF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.54M | -41.38M | -42.37M | -41.08M | -40.03M |
| Total Depreciation and Amortization | 1.56M | 1.54M | 1.50M | 1.47M | 1.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | 692.90K | 1.41M |
| Total Other Non-Cash Items | 938.00K | 2.62M | 4.22M | 1.60M | -1.06M |
| Change in Net Operating Assets | -8.05M | -6.69M | -5.26M | 3.84M | 13.18M |
| Cash from Operations | -45.10M | -43.91M | -41.91M | -33.46M | -25.05M |
| Capital Expenditure | -1.40M | -1.19M | -961.90K | -1.20M | -1.45M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101.51M | -112.03M | -122.60M | -61.97M | -1.10M |
| Cash from Investing | -102.92M | -113.22M | -123.56M | -63.17M | -2.55M |
| Total Debt Issued | -20.30M | -20.30M | -20.30M | -20.15M | -20.00M |
| Total Debt Repaid | 0.00 | -8.50K | -17.00K | -53.50K | -90.00K |
| Issuance of Common Stock | 105.11M | 105.11M | 105.11M | 52.61M | 111.00K |
| Repurchase of Common Stock | -12.00K | -6.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.83M | 39.87M | 49.90M | 48.82M | 47.75M |
| Cash from Financing | 133.73M | 145.12M | 155.67M | 93.06M | 30.28M |
| Foreign Exchange rate Adjustments | -330.10K | -1.14M | -1.89M | -1.50M | -1.10M |
| Miscellaneous Cash Flow Adjustments | 1.20K | 600.00 | 100.00 | -500.00 | -1.10K |
| Net Change in Cash | -14.61M | -13.15M | -11.69M | -5.08M | 1.57M |